Search

everythinglearnresearchcommunity

for

Search:↓

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Thermal spring waters and their microbes could be good for skin health and treating some skin conditions in skincare products.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Certain genes are more active during wound healing in axolotl and Acomys, which could help develop materials that improve human wound healing and regeneration.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Antibody treatments show promise for hair loss but need more research.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Blocking the protein CXCL12 with a specific antibody can increase hair growth in common hair loss conditions.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

PCOS is linked to low-grade chronic inflammation.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The research suggests that autophagy-related genes might play a role in causing alopecia areata.

Substance from human umbilical cord blood cells promotes hair growth.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Wound covers with α-13'-COOH from vitamin E can improve and speed up wound healing.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Hair color is not a risk factor for developing alopecia areata.

Erdr1 could be a new marker for diagnosing hair loss.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Physical activity, height, and smoking affect prostate cancer risk.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.